NPS and obesity disorder: Further studies are now needed to investigate whether the mechanisms observed here with exogenous OX-A also occur with the endogenously produced neuropeptide during conditions characterized by dysbiosis and LPS-driven systemic inflammation, such as obesity and ensuing neuroinflammatory pathologies.